Autologous CD8+ T-cells Expressing an Anti-BCMA CAR in Patients With Myeloma

NCT03448978 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

32

Enrollment

INDUSTRY

Sponsor class

Stopped Phase 1 enrollment completed. Further clinical development terminated

Conditions

Multiple Myeloma

Interventions

BIOLOGICAL: Descartes-08
DRUG: Fludarabine
DRUG: Cyclophosphamide

Sponsor

Cartesian Therapeutics